Oxaloacetate decarboxylase FAHD1 - a new regulator of mitochondrial function and senescence.


Journal

Mechanisms of ageing and development
ISSN: 1872-6216
Titre abrégé: Mech Ageing Dev
Pays: Ireland
ID NLM: 0347227

Informations de publication

Date de publication:
01 2019
Historique:
received: 22 02 2018
revised: 02 07 2018
accepted: 25 07 2018
pubmed: 29 7 2018
medline: 26 4 2019
entrez: 29 7 2018
Statut: ppublish

Résumé

FAHD1, a member of the FAH superfamily of enzymes, was identified in a proteomic screen for mitochondrial proteins with differential expression in young versus senescent human endothelial cells. FAHD1 acts as oxaloacetate decarboxylase, and recent observations suggest that FAHD1 plays an important role in regulating mitochondrial function. Thus, mutation of the nematode homolog, fahd-1, impairs mitochondrial function in Caenorhabditis elegans. When FAHD1 gene expression was silenced in human cells, activity of the mitochondrial electron transport (ETC) system was reduced and the cells entered premature senescence-like growth arrest. These findings suggest a model where FAHD1 regulates mitochondrial function and in consequence senescence. These findings are discussed here in the context of a new concept where senescence is divided into deep senescence and less severe forms of senescence. We propose that genetic inactivation of FAHD1 in human cells induces a specific form of cellular senescence, which we term senescence light and discuss it in the context of mitochondrial dysfunction associated senescence (MiDAS) described by others. Together these findings suggest the existence of a continuum of cellular senescence phenotypes, which may be at least in part reversible.

Identifiants

pubmed: 30055189
pii: S0047-6374(18)30041-1
doi: 10.1016/j.mad.2018.07.007
pii:
doi:

Substances chimiques

FAHD1 protein, human EC 3.-
Hydrolases EC 3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-29

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Solmaz Etemad (S)

University of Innsbruck, Research Institute for Biomedical Ageing Research, Rennweg 10, A-6020 Innsbruck, Austria; University of Innsbruck, Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80-82, A-6020 Innsbruck, Austria.

Michèle Petit (M)

University of Innsbruck, Research Institute for Biomedical Ageing Research, Rennweg 10, A-6020 Innsbruck, Austria; University of Innsbruck, Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80-82, A-6020 Innsbruck, Austria.

Alexander K H Weiss (AKH)

University of Innsbruck, Research Institute for Biomedical Ageing Research, Rennweg 10, A-6020 Innsbruck, Austria; University of Innsbruck, Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80-82, A-6020 Innsbruck, Austria.

Andre Schrattenholz (A)

ProteoSys GmbH, Carl-Zeiss-Straße 51, 55129 Mainz, Germany.

Giorgia Baraldo (G)

University of Innsbruck, Research Institute for Biomedical Ageing Research, Rennweg 10, A-6020 Innsbruck, Austria; University of Innsbruck, Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80-82, A-6020 Innsbruck, Austria.

Pidder Jansen-Dürr (P)

University of Innsbruck, Research Institute for Biomedical Ageing Research, Rennweg 10, A-6020 Innsbruck, Austria; University of Innsbruck, Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80-82, A-6020 Innsbruck, Austria. Electronic address: pidder.jansen-duerr@uibk.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH